$89 a month for semaglutide. That is the pitch. This altRx review is about everything the pitch leaves out.
Start with the numbers. BBB rating: F, with 39 complaints the company never answered. Trustpilot: 2.5 out of 5, with 51% one-star reviews. And on June 8, 2026, the FDA sent a warning letter to altRx’s operator, Trinity HealthCare Supply, LLC, over misleading GLP-1 marketing on the altRx website.
We score altRx 6 out of 10 — Fair. That is the lowest score of any provider we rank. Here is the full case, dollar by dollar.
altRx in 60 Seconds
altRx is a telehealth weight-loss brand that ships compounded semaglutide from $89/mo and compounded tirzepatide from $149/mo to all 50 states. It also sells brand-name Ozempic, Wegovy, and Zepbound — at $1,149 to $1,579 a month, cash only. Insurance is not accepted.
The company is new. Its BBB file opened on May 5, 2026, and it earned an F rating within months by ignoring 39 complaints. Its BBB profile lists a Miami address that is a PMB — a private mailbox, not an office.
The legal name behind the brand matters here. altRx is operated by Trinity HealthCare Supply, LLC — the same entity named in press materials for Trinity Meds, which we score 6.8/10. In June 2026, that LLC received an FDA warning letter about the altRx website. More on that below.
The altRx Review Scorecard
| Metric | The number |
|---|---|
| Our rating | 6/10 — Fair |
| Advertised starting price | $89/mo (compounded semaglutide) |
| BBB rating | F, 39 unanswered complaints |
| Trustpilot score | 2.5/5, 51% one-star (~148 reviews) |
| FDA warning letter | Yes — June 8, 2026 (MARCS-CMS 728236) |
| Refunds after processing | None |
| States served | 50 |
| Shipping | Free, 4-5 business days |
One more baseline before the money talk. The drugs behind these programs are real. In the STEP 1 trial, adults on semaglutide 2.4 mg lost an average of 14.9% of body weight over 68 weeks. In SURMOUNT-1, tirzepatide produced up to 20.9% average loss over 72 weeks. But those trials tested the FDA-approved brand products. Compounded copies are not FDA-approved, and altRx’s own disclaimer says the FDA has not evaluated them for safety, efficacy, or quality.
altRx Cost Breakdown (2026)
The altRx price list looks aggressive on paper. Every compounded plan claims the same price at every dose, no membership fee, and $0 shipping.
| Product | Advertised price | The fine print |
|---|---|---|
| Compounded semaglutide | $89/mo (shown as marked down from $199/mo) | Not FDA-approved; complaints allege later bills of $189-$199 |
| Compounded semaglutide, 12-month plan | $75/mo | Long commitment to a company with an F BBB rating |
| Compounded tirzepatide | $149/mo (shown as marked down from $299/mo) | Not FDA-approved |
| Brand-name Ozempic | from $1,149/mo | Cash pay; no insurance accepted |
| Brand-name Zepbound | from $1,249/mo | Cash pay |
| Brand-name Wegovy | from $1,579/mo | Cash pay |
Now the math. At the advertised rate, a year of compounded semaglutide costs $1,068 — or $900 on the $75/mo annual plan. That would be one of the cheapest offers we track.
But here is the problem. BBB and Trustpilot complaints repeatedly allege that customers who signed up at $89 were billed $189 to $199 in later cycles. At $189, that same year costs $2,268 — a $1,200 swing from the headline. The site claims “no price hike.” The complaint record says otherwise, and that gap is why the price gets no benefit of the doubt in this review. To see what honest market rates look like, check our semaglutide cost breakdown.
The refund policy makes the risk worse. No refunds once a prescription order is approved, processing, or shipped. altRx only refunds if you are found medically ineligible at the first consult, or for a verifiable billing error claimed within 28 days. Miss that window on a disputed charge and you are stuck.
Payment details: no insurance, FSA-eligible, and you can pause or cancel the membership anytime — though cancelling does not claw back a charge already in processing.
What Customers Complain About — and What They Praise
The complaint file is unusually loud for a company this young. Trustpilot shows a 2.5/5 “Poor” score across roughly 148 reviews, with 51% one-star. An earlier snapshot showed 3.4/5 — so the score is falling, not recovering.
Complaint theme #1 is billing. Reviewers on both Trustpilot and the BBB allege they were advertised $89/mo and then charged $189 to $199. These are customer allegations, not court findings — but the same story, told dozens of times, from the company selling a “no price hike” promise, is the single biggest red flag in this altRx review’s research file.
Complaint theme #2 is silence. The BBB assigns its F rating specifically because altRx failed to respond to 39 complaints. Oddly, the company does reply to about 67% of negative Trustpilot reviews — it engages where the public is watching and ignores the formal channel. Trustpilot also notes it has removed fake reviews posted for this company.
What do customers praise? Not much is documented, and we will not invent it. The earlier 3.4/5 snapshot suggests some buyers got what they ordered. The features that draw people in are real on paper: flat dose pricing, $0 shipping, delivery in 4-5 business days, and four named partner pharmacies. The gap between that pitch and the 51% one-star reality is the whole story.
The One Thing Every altRx Review Must Cover: The FDA Warning Letter
On June 8, 2026, the FDA issued warning letter MARCS-CMS 728236 to Trinity HealthCare Supply, LLC dba altRx of Miami, FL. The letter cites misbranding and misleading claims about compounded semaglutide and tirzepatide on the altRx website, under sections 502(a) and 502(bb) of the FD&C Act.
Read that plainly: the federal drug regulator told this company, in writing, that its marketing of these exact products was misleading. That is not a routine paperwork notice. It lands on top of the FDA’s broader published concerns about unapproved GLP-1 drugs — dosing errors, unverified ingredients, and products the agency has never reviewed.
The corporate connection matters too. The same LLC is identified in press materials as the operator behind sister brand Trinity Meds (6.8/10 on our scale), which has its own 2.1/5 Trustpilot score and inconsistent pricing across its own pages. One operator, two brands, two poor track records. That pattern drove altRx’s score down as much as any single complaint.
How Ordering From altRx Works
The funnel itself is standard telehealth. Here is the flow, with the checkpoints we would watch.
Step 1: A 2-minute online assessment. You answer health questions and pick a medication. Minimum age is 18. The site states plainly that a prescription is never guaranteed.
Step 2: Clinician review. A licensed MD, DO, PA, or NP — credentialed through affiliated practices such as Usable Health, PC — reviews your intake. Depending on your state, this is a live video visit or a fully asynchronous review with no appointment. No lab work requirement is mentioned anywhere, which is thinner screening than the best clinics on our list.
Step 3: Pharmacy fulfillment. Approved prescriptions go to one of four named, state-licensed 503A compounding pharmacies: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, or Casa Pharma Rx. Naming its pharmacies is genuinely more transparent than many rivals — credit where due. Note that 503A pharmacies compound patient-specific prescriptions and their products are not FDA-approved.
Step 4: Delivery. Free shipping, arriving in about 4-5 business days. The monthly price — $89, $149, or $1,149+ depending on product — covers the consult, care plan, prescription, and shipping with no separate membership fee.
If you proceed despite everything above, protect yourself: screenshot the checkout price, save the confirmation email, pay with a card that makes disputes easy, and check your statement every cycle against the $89 you agreed to. The 28-day billing-error window is short.
altRx vs bmiMD
Our top alternative is bmiMD (8.2/10 — Very Good). It sells the same category of product — compounded GLP-1s at a flat price per dose — without the regulatory baggage.
| altRx | bmiMD | |
|---|---|---|
| Our score | 6/10 — Fair | 8.2/10 — Very Good |
| Semaglutide price | $89/mo advertised | $99/mo (12-month plan); $129/mo monthly |
| Tirzepatide price | $149/mo | From $139/mo; $89.50 first-month promo |
| BBB record | F, 39 unanswered complaints | C+, 38 complaints, 1 unanswered |
| Trustpilot | 2.5/5, 51% one-star | About 4/5 across 800+ reviews |
| FDA warning letter | Yes — June 2026 | None documented |
| If you are ineligible | Refund at initial consult only | Card only authorized — $0 charged |
| Quality testing | Not published | Potency within 10%, USP 797 sterility, third-party labs |
Yes, altRx is $10/mo cheaper on the monthly headline. But bmiMD publishes third-party potency and sterility testing, holds its price history clean, and does not charge your card until a provider approves you. A $120-per-year saving does not cover the risk of a $189 surprise bill. bmiMD’s fine print has real teeth too — a $50 cancellation fee window and all-sales-final terms — which is why it scores 8.2 and not higher. Read the full bmiMD review before you buy, and compare the whole budget field in our best GLP-1 under $150 ranking, where legit options start near altRx’s price without the F rating.
Final Verdict: Who Should Actually Buy
altRx: 6/10 — Fair. The bottom score on our board, and it earned it.
We could not build an honest buyer profile for this company as of July 2026. Budget shoppers can get compounded semaglutide from $99/mo at bmiMD with a far cleaner record. Brand-name buyers should not pay altRx $1,149 to $1,579 a month when the same FDA-approved drugs exist elsewhere with price-match tools and better support. Even among low scorers, Sprout Health (6.4/10) and sister brand Trinity Meds (6.8/10) rank ahead of it.
The scoreboard is simple. One FDA warning letter. One BBB F rating. 39 ignored complaints. 51% one-star reviews. Against that, an $89 price tag that dozens of customers allege became $189.
Cheap only counts if the number on the ad matches the number on your statement. At altRx, the documented record says you cannot count on that. Spend the extra $10 a month. Skip this one.